Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
NEW YORK (Reuters Health) – After primary surgery for early-stage endometrial cancer, adjuvant external beam radiation therapy confers no survival benefit overall, according to a Norwegian study. In…
Many of Uganda’s health centers are located in remote areas, where there is not adequate health information and poor delivery systems. Subsequently, these facilities are not able to…
Born with a rare neuromuscular condition called Arthrogryposis Multiplex Congenita, two-year-old Emma Lavelle has severely contracted joints and muscle weakness leaving her without the ability to lift her…
Drug and alcohol addiction is often a chronic or ongoing problem like smoking and depression. Many health systems are looking to treat these conditions by implementing coordinated chronic…
NEW YORK (Reuters Health) – Among several different DNA-based quantitative polymerase chain reaction (qPCR) assays for detecting a critical JAK2 mutation in myeloproliferative neoplasms, one stands out as…
NEW YORK (Reuters Health) – There’s no evidence that starting treatment with the anti-obesity drug orlistat raises the likelihood of developing colorectal cancer, at least in the short…
The Affordable Care Act includes a pay for performance program designed to promote high quality health care. A new study examined if financial incentives paid to physicians and…
By Anne Harding NEW YORK (Reuters Health) – Pediatric inflammatory bowel disease (IBD) patients are not at increased mortality risk compared with their IBD-free peers, but they do…
NEW YORK (Reuters Health) – The identification of differing patterns of oncogenic mutations in squamous cell carcinoma and adenocarcinoma of the cervix may lead to more targeted treatments,…
